(LZM) Lifezone Metals - Overview
Exchange: NYSE •
Country: Isle of Man •
Currency: USD •
Type: Common Stock •
ISIN: IM00BLCY1J27
Stock: Nickel, Recycling, Licensing
Total Rating 20
Risk 36
Buy Signal -0.24
| Risk 5d forecast | |
|---|---|
| Volatility | 81.2% |
| Relative Tail Risk | -9.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.09 |
| Alpha | -39.47 |
| Character TTM | |
|---|---|
| Beta | 1.211 |
| Beta Downside | 0.741 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.11% |
| CAGR/Max DD | -0.28 |
Description: LZM Lifezone Metals December 29, 2025
Lifezone Metals Limited (NYSE:LZM) is a metals production and recycling firm headquartered in Douglas, Isle of Man. Its flagship asset is the Kabanga Nickel Project in north-west Tanzania, a laterite deposit currently undergoing feasibility studies, while the company also generates revenue through intellectual-property licensing.
Key metrics and sector drivers to note: (1) Kabanga’s JORC-compliant inferred resource is estimated at ~4 Mt of nickel, positioning it among the larger African projects; (2) The project targets an initial output of ~30,000 t of nickel per year, which would make it sensitive to nickel price swings-prices have risen above $20,000/t in 2024 driven by EV battery demand; (3) Lifezone’s market capitalization is roughly $150 m, giving it a market-cap-to-resource ratio that is below the sector median, suggesting a potential valuation discount relative to peers.
If you want a data-rich, unbiased assessment of LZM’s valuation and risk profile, a quick look at its page on ValueRay could be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -86.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.62 > 0.02 and ΔFCF/TA -8.14 > 1.0 |
| NWC/Revenue: -5547 % < 20% (prev 333.9%; Δ -5881 % < -1%) |
| CFO/TA -0.17 > 3% & CFO -25.2m > Net Income -86.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.5m) vs 12m ago 9.30% < -2% |
| Gross Margin: -37.53% > 18% (prev 0.05%; Δ -3758 % > 0.5%) |
| Asset Turnover: 0.33% > 50% (prev 0.89%; Δ -0.56% > 0%) |
| Interest Coverage Ratio: -9.94 > 6 (EBITDA TTM -81.9m / Interest Expense TTM 8.42m) |
Altman Z'' -15.00
| A: -0.21 (Total Current Assets 14.5m - Total Current Liabilities 45.2m) / Total Assets 148.6m |
| B: -3.04 (Retained Earnings -451.8m / Total Assets 148.6m) |
| C: -0.51 (EBIT TTM -83.7m / Avg Total Assets 165.0m) |
| D: -8.35 (Book Value of Equity -383.8m / Total Liabilities 46.0m) |
| Altman-Z'' Score: -23.45 = D |
Beneish M -4.00
| DSRI: 1.29 (Receivables 769.7k/1.74m, Revenue 552.6k/1.62m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.10 (AQ_t 0.01 / AQ_t-1 0.06) |
| SGI: 0.34 (Revenue 552.6k / 1.62m) |
| TATA: -0.41 (NI -86.3m - CFO -25.2m) / TA 148.6m) |
| Beneish M-Score: -4.22 (Cap -4..+1) = AAA |
What is the price of LZM shares?
As of February 08, 2026, the stock is trading at USD 4.85 with a total of 118,092 shares traded.
Over the past week, the price has changed by -8.32%, over one month by -3.39%, over three months by +27.97% and over the past year by -21.01%.
Over the past week, the price has changed by -8.32%, over one month by -3.39%, over three months by +27.97% and over the past year by -21.01%.
Is LZM a buy, sell or hold?
Lifezone Metals has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy LZM.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LZM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.8 | 123.1% |
| Analysts Target Price | 10.8 | 123.1% |
| ValueRay Target Price | 4.7 | -3.1% |
LZM Fundamental Data Overview February 04, 2026
P/S = 1064.6036
P/B = 5.2885
Revenue TTM = 552.6k USD
EBIT TTM = -83.7m USD
EBITDA TTM = -81.9m USD
Long Term Debt = 431.7k USD (from longTermDebtTotal, last quarter)
Short Term Debt = 30.9m USD (from shortTermDebt, last quarter)
Debt = 31.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.9m USD (from netDebt column, last quarter)
Enterprise Value = 352.3m USD (333.5m + Debt 31.4m - CCE 12.5m)
Interest Coverage Ratio = -9.94 (Ebit TTM -83.7m / Interest Expense TTM 8.42m)
EV/FCF = -3.80x (Enterprise Value 352.3m / FCF TTM -92.8m)
FCF Yield = -26.34% (FCF TTM -92.8m / Enterprise Value 352.3m)
FCF Margin = -16.8k% (FCF TTM -92.8m / Revenue TTM 552.6k)
Net Margin = -15.6k% (Net Income TTM -86.3m / Revenue TTM 552.6k)
Gross Margin = -37.53% ((Revenue TTM 552.6k - Cost of Revenue TTM 760.0k) / Revenue TTM)
Gross Margin QoQ = -76.21% (prev 17.88%)
Tobins Q-Ratio = 2.37 (Enterprise Value 352.3m / Total Assets 148.6m)
Interest Expense / Debt = 15.55% (Interest Expense 4.88m / Debt 31.4m)
Taxrate = 8.76% (180.8k / 2.07m)
NOPAT = -76.4m (EBIT -83.7m * (1 - 8.76%)) [loss with tax shield]
Current Ratio = 0.32 (Total Current Assets 14.5m / Total Current Liabilities 45.2m)
Debt / Equity = 0.34 (Debt 31.4m / totalStockholderEquity, last quarter 93.2m)
Debt / EBITDA = -0.23 (negative EBITDA) (Net Debt 18.9m / EBITDA -81.9m)
Debt / FCF = -0.20 (negative FCF - burning cash) (Net Debt 18.9m / FCF TTM -92.8m)
Total Stockholder Equity = 90.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -52.32% (Net Income -86.3m / Total Assets 148.6m)
RoE = -95.43% (Net Income TTM -86.3m / Total Stockholder Equity 90.4m)
RoCE = -92.13% (EBIT -83.7m / Capital Employed (Equity 90.4m + L.T.Debt 431.7k))
RoIC = -61.84% (negative operating profit) (NOPAT -76.4m / Invested Capital 123.5m)
WACC = 10.71% (E(333.5m)/V(364.8m) * Re(10.38%) + D(31.4m)/V(364.8m) * Rd(15.55%) * (1-Tc(0.09)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.37%
Fair Price DCF = unknown (Cash Flow -92.8m)
EPS Correlation: -7.59 | EPS CAGR: 0.0% | SUE: 0.07 | # QB: 0
Revenue Correlation: -69.31 | Revenue CAGR: -22.22% | SUE: 0.16 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.33 | Chg30d=N/A | Revisions Net=-1 | Growth EPS=-175.0% | Growth Revenue=-100.0%
P/B = 5.2885
Revenue TTM = 552.6k USD
EBIT TTM = -83.7m USD
EBITDA TTM = -81.9m USD
Long Term Debt = 431.7k USD (from longTermDebtTotal, last quarter)
Short Term Debt = 30.9m USD (from shortTermDebt, last quarter)
Debt = 31.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.9m USD (from netDebt column, last quarter)
Enterprise Value = 352.3m USD (333.5m + Debt 31.4m - CCE 12.5m)
Interest Coverage Ratio = -9.94 (Ebit TTM -83.7m / Interest Expense TTM 8.42m)
EV/FCF = -3.80x (Enterprise Value 352.3m / FCF TTM -92.8m)
FCF Yield = -26.34% (FCF TTM -92.8m / Enterprise Value 352.3m)
FCF Margin = -16.8k% (FCF TTM -92.8m / Revenue TTM 552.6k)
Net Margin = -15.6k% (Net Income TTM -86.3m / Revenue TTM 552.6k)
Gross Margin = -37.53% ((Revenue TTM 552.6k - Cost of Revenue TTM 760.0k) / Revenue TTM)
Gross Margin QoQ = -76.21% (prev 17.88%)
Tobins Q-Ratio = 2.37 (Enterprise Value 352.3m / Total Assets 148.6m)
Interest Expense / Debt = 15.55% (Interest Expense 4.88m / Debt 31.4m)
Taxrate = 8.76% (180.8k / 2.07m)
NOPAT = -76.4m (EBIT -83.7m * (1 - 8.76%)) [loss with tax shield]
Current Ratio = 0.32 (Total Current Assets 14.5m / Total Current Liabilities 45.2m)
Debt / Equity = 0.34 (Debt 31.4m / totalStockholderEquity, last quarter 93.2m)
Debt / EBITDA = -0.23 (negative EBITDA) (Net Debt 18.9m / EBITDA -81.9m)
Debt / FCF = -0.20 (negative FCF - burning cash) (Net Debt 18.9m / FCF TTM -92.8m)
Total Stockholder Equity = 90.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -52.32% (Net Income -86.3m / Total Assets 148.6m)
RoE = -95.43% (Net Income TTM -86.3m / Total Stockholder Equity 90.4m)
RoCE = -92.13% (EBIT -83.7m / Capital Employed (Equity 90.4m + L.T.Debt 431.7k))
RoIC = -61.84% (negative operating profit) (NOPAT -76.4m / Invested Capital 123.5m)
WACC = 10.71% (E(333.5m)/V(364.8m) * Re(10.38%) + D(31.4m)/V(364.8m) * Rd(15.55%) * (1-Tc(0.09)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.37%
Fair Price DCF = unknown (Cash Flow -92.8m)
EPS Correlation: -7.59 | EPS CAGR: 0.0% | SUE: 0.07 | # QB: 0
Revenue Correlation: -69.31 | Revenue CAGR: -22.22% | SUE: 0.16 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.33 | Chg30d=N/A | Revisions Net=-1 | Growth EPS=-175.0% | Growth Revenue=-100.0%